Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes.

Starlink controversy, AI psychosis debates, invisible malware takedowns, and dangerous MCP vulnerabilities dominated this ...